Follow
Hugh Barrett
Hugh Barrett
Adjunct Professor, School of Biomedical Sciences, University of Western Australia
Verified email at uwa.edu.au - Homepage
Title
Cited by
Cited by
Year
SAAM II: simulation, analysis, and modeling software for tracer and pharmacokinetic studies
PHR Barrett, BM Bell, C Cobelli, H Golde, A Schumitzky, P Vicini, ...
Metabolism 47 (4), 484-492, 1998
5051998
Apolipoprotein C-III: understanding an emerging cardiovascular risk factor
EMM Ooi, PHR Barrett, DC Chan, GF Watts
Clinical science 114 (10), 611-624, 2008
4152008
Waist circumference, waist-to-hip ratio and body mass index as predictors of adipose tissue compartments in men
DC Chan, GF Watts, PHR Barrett, V Burke
Qjm 96 (6), 441-447, 2003
4042003
Randomized controlled trial of the effect of n–3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity
DC Chan, GF Watts, TA Mori, PHR Barrett, TG Redgrave, LJ Beilin
The American journal of clinical nutrition 77 (2), 300-307, 2003
3692003
The role of the LDL receptor in apolipoprotein B secretion
J Twisk, DL Gillian-Daniel, A Tebon, L Wang, PHR Barrett, AD Attie
The Journal of clinical investigation 105 (4), 521-532, 2000
2982000
Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo AI in healthy men
B Lamarche, KD Uffelman, A Carpentier, JS Cohn, G Steiner, PH Barrett, ...
The Journal of clinical investigation 103 (8), 1191-1199, 1999
2881999
Lipid Disorders and Mutations in the APOB Gene
AJ Whitfield, PHR Barrett, FM van Bockxmeer, JR Burnett
Clinical chemistry 50 (10), 1725-1732, 2004
2852004
Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome
GF Watts, PHR Barrett, J Ji, AP Serone, DC Chan, KD Croft, F Loehrer, ...
Diabetes 52 (3), 803-811, 2003
2432003
Association of adiponectin and resistin with adipose tissue compartments, insulin resistance and dyslipidaemia
MS Farvid, TWK Ng, DC Chan, PHR Barrett, GF Watts
Diabetes, obesity and metabolism 7 (4), 406-413, 2005
2332005
Effect of atorvastatin and fish oil on plasma high-sensitivity C-reactive protein concentrations in individuals with visceral obesity
DC Chan, GF Watts, PHR Barrett, LJ Beilin, TA Mori
Clinical Chemistry 48 (6), 877-883, 2002
2232002
Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemia
DC Chan, GF Watts, PHR Barrett, LJ Beilin, TG Redgrave, TA Mori
Diabetes 51 (8), 2377-2386, 2002
2032002
Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) AI and ApoB-containing lipoproteins
S Lamon-Fava, MR Diffenderfer, PHR Barrett, A Buchsbaum, M Nyaku, ...
Arteriosclerosis, thrombosis, and vascular biology 28 (9), 1672-1678, 2008
1902008
Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss diet
DC Chan, GF Watts, SK Gan, EMM Ooi, PHR Barrett
Diabetes Care 33 (5), 1134-1139, 2010
1802010
Dyslipidemia in visceral obesity: mechanisms, implications, and therapy
DC Chan, HPR Barrett, GF Watts
American Journal of Cardiovascular Drugs 4, 227-246, 2004
1752004
Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women
NR Matthan, FK Welty, PHR Barrett, C Harausz, GG Dolnikowski, ...
Arteriosclerosis, Thrombosis, and Vascular Biology 24 (6), 1092-1097, 2004
1712004
Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration
DC Chan, GF Watts, TG Redgrave, TA Mori, PHR Barrett
Metabolism-Clinical and Experimental 51 (8), 1041-1046, 2002
1712002
Adiponectin and other adipocytokines as predictors of markers of triglyceride-rich lipoprotein metabolism
DC Chan, GF Watts, TWK Ng, Y Uchida, N Sakai, S Yamashita, ...
Clinical chemistry 51 (3), 578-585, 2005
1612005
Personal model‐assisted identification of NAD+ and glutathione metabolism as intervention target in NAFLD
A Mardinoglu, E Bjornson, C Zhang, M Klevstig, S Söderlund, M Stċhlman, ...
Molecular systems biology 13 (3), 916, 2017
1572017
Effect of dietary fatty acids on human lipoprotein metabolism: a comprehensive update
EMM Ooi, GF Watts, TWK Ng, PHR Barrett
Nutrients 7 (6), 4416-4425, 2015
1462015
Hepatocyte apoB-containing lipoprotein secretion is decreased by the grapefruit flavonoid, naringenin, via inhibition of MTP-mediated microsomal triglyceride accumulation
NM Borradaile, LE de Dreu, PHR Barrett, CD Behrsin, MW Huff
Biochemistry 42 (5), 1283-1291, 2003
1442003
The system can't perform the operation now. Try again later.
Articles 1–20